Stockreport

Orgenesis shares soar 19% premarket as FDA gives orphan status to insulin tech [MarketWatch]

Orgenesis Inc.  (ORGS) 
NASDAQ:AMEX Investor Relations: orgenesis.com
PDF Orgenesis shares soar 19% premarket after FDA grants orphan designation to insulin tech Orgenesis Inc. shares ORGS, -1.83% soared 19% in premarket trade Monday, after [Read more]